Monday 21/August/2023 – 09:36 PM
issued drug authority During the last period of the month of August, the Egyptian Ministry issued warnings to citizens and health service providers against counterfeit packages of therapeutic drugs in the Egyptian pharmaceutical market.
It warns of counterfeit packaging for 5 drugs in August
The Egyptian Medicines Authority warned against counterfeit packages of Ciprobay tablets, Hi-biotic N 600 mg suspension, Zilone Forte, Tavanic 500 mg tablets, Oxyprogest injections, and a batch of Viovact 108 mg.
The Egyptian Medicines Authority stated that there are imitated packages of Ciprobay drug, concentration tablets of 500 mg, bearing batch number 471, as well as imitated packages of Ciprobay tablets, concentration of 750 mg, operating number 280, noting that this medicinal product is used as an antibiotic to treat urinary tract infections and infection lower respiratory tract.
The FDA added that the counterfeit packages of Hi-biotic N 600 mg suspension, used in the treatment of bacterial sinusitis and pneumonia, bear batch number 216402, while the counterfeit packages of Zylon Forte, used in the treatment of endocrine disorders, bear batch number. 4521001 and 351017.
Withdraw a batch of a medicinal product
The FDA warned against counterfeit packages of Tavanic 500 mg tablets, which bear batch number CEG014, which is used as an antibiotic in the treatment of pneumonia and chronic prostatitis, indicating that there are counterfeit packages of Oxyprogest, bearing batch number 23301002, which is used to prevent pregnancy. and treatment of endometrial cancer.
And the Egyptian Medicines Authority decided to seize and seize all packages of Viovact 108 mg from batch No. P02321B, which is used in cases of severe breathing difficulty in children, explaining that the reason is due to their non-conformity with the authority’s specifications.
2023-08-21 18:37:32
#names. #Medicines #Authority #warns #counterfeit #packages #medicines #market
